Effect of an orally active Th2 cytokine inhibitor, suplatast tosilate, on atopic cough

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 6, 2008, Pages 297-302

  Ishiura, Yoshihisa ^a   Fujimura, Masaki ^b   Yamamoto, Hiroki ^a   Nobata, Kouichi ^b   Ishiguro, Takashi ^a   Ogawa, Haruhiko ^b   Myou, Shigeharu ^b  

^a Toyama City Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Antiallergic agents; CAS 94055 76 2; Clinical study; Effect on cough reflex sensitivity; Eosinophilic tracheobronchitis; IPD ; Suplatast tosilate; Th2 cytokines

Indexed keywords

ANTIALLERGIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; CAPSAICIN; CORTICOSTEROID; CYTOKINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; PLACEBO; SUPLATAST TOSYLATE; TERFENADINE;

ADULT; AGED; ARTICLE; ATOPIC COUGH; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGH REFLEX SENSITIVITY; COUGH THRESHOLD; COUGHING; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIC TRACHEOBRONCHITIS; FEMALE; FORCED EXPIRATORY VOLUME; HELPER CELL; HUMAN; MALE; PARAMETER; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRACHEOBRONCHITIS; TREATMENT PLANNING;

EID: 46949110451     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296510     Document Type: Article

References (30)

1. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med. 1999;160:406-410.
2. Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med. 1997; 156:211-216.
3. Ayik SO, Basoglu OK, Erdinc M, Bor S, Veral A, Bilgen C. Eosinophilic bronchitis as a cause of chronic cough. Respir Med. 2003;97:695-701.
4. Fujimura M, Sakamoto S, Matsuda T. Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness. Intern Med. 1992;31:447-452.
5. Fujimura M, Ogawa H, Yasui M, Matsuda T. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin Exp Allergy. 2000;30:41-47.
6. Fujimura M, Ogawa H, Nishizawa Y, Nishi K. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax. 2003;58:14-18.
7. Fujimura M, Nishizawa Y, Nishitsuji M, Abo M, Kita T, Nomura S. Longitudinal decline in pulmonary function in atopic cough and cough variant asthma. Clin Exp Allergy. 2003;33:588-594.
8. Committee for the Japanese Respiratory Society Guidelines for Management of Cough, Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology. 2006;11:135S-186S.
9. Fujimura M. Cough variant asthma and related disorders: atopic cough (in Japanese). Arerugi no rinsho. 1996;16:22-27.
10. Shioya T, Satake M, Kagaya M, Sano MA, Watanabe A, Fukui S, et al. Antitussive effects of the H1-receptor antagonist epinastine in patients with atopic cough (eosinophilic bronchitis). Arzneimittel-Forschung (Drug Research). 2004;54:207-212.
11. Fujimura M, Nishi K, Ohka T, Yasui M, Kasahara K. Bronchial biopsy and sequential bronchoalveolar lavage in atopic cough: In view of the effect of histamine H1-receptor antagonists. Allergol Int. 2000;49:135-142.
12. Shirai T, Suzuki K, Inui N, Suda T, Chida K, Nakamura H. Thl/Th2 profile in peripheral blood in atopic cough and atopic asthma. Clin Exp Allergy. 2003;33:84-89.
13. Yanagihara Y, Kiniwa M, Ikizawa T, Shida N, Matsuura N, Koda A. Supression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: Regulation of human IgE response. Jap J Pharmacol. 1993;61:23-39.
14. Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double blind randomized study. Lancet. 2000;356:273-278.
15. Sano Y, Suzuki N, Yamada H, To Y, Ogawa C, Ohta K, Adachi M. Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma. J Allergy Clin Immunol. 2003;111:958-966.
16. Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. Eur J Clin Pharmacol. 2002;58:171-176.
17. IshiuraY, Fujimura M, Nobata K, Myou S, Oribe Y, Abo M, et al. Th2 cytokine inhibition and cough in asthmatic and bronchitic patients. Ann Med. 2004;36:623-629.
18. American Thoracic Society. Standarization of spirometry: 1987 update. Am Rev Respir Dis. 1987;136:1285-1298.
19. Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy. 1977;7:503-513.
20. Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effects of methacholine-induced bronchoconstriction and procaterol-induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax. 1992;47:441-445.
21. Ishiura Y, Fujimura M, Saito M, Shibata K, Nomura M, Nakatsumi Y, et al. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. Respir Med. 1995;89:677-684.
22. Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K, et al. Thromboxane antagonism and cough in chronic bronchitis. Ann Med. 2003;35:135-139.
23. Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy. J Asthma.. 1994;31:463-472.
24. 1-receptor antagonist on antigen-induced increase of sensitivity in guinea pigs. Allergol Int. 2000;49:237-243.
25. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344:30-37.
26. McGarvey L, Morice AH. Atopic cough: little evidence to support a new clinical entity. Thorax. 2003;58:736-737; author reply 737-738.
27. Fujimura M, Ogawa H. Atopic cough: little evidence to support a new clinical entity; author reply. Thorax. 2003;58:737-738.
28. Gibson PG. Atopic cough. Thorax. 2004;59:449.
29. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:116S-121S.
30. Brightiing CE, Symon FA, Birring SS, Bradding P, Pavord ID, Wardlaw AJ. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol. 2002;110:899-905.